THCMEDIUM SIGNALFINANCIAL10-K

THC's operating cash flow grew substantially while reported operating income declined meaningfully, creating a notable divergence between earnings and cash generation that warrants investor scrutiny.

The meaningful decline in operating income (~41%) alongside substantially higher operating cash flow (~73%) suggests significant non-cash or working capital dynamics at work — such as depreciation, amortization, or favorable working capital movements — that are masking the earnings-level pressure. Investors should examine whether the operating income decline reflects one-time charges, asset write-downs, or structural margin compression. The combination of a larger hospital and ambulatory care footprint (50 hospitals, 533 ASCs vs. 49 hospitals, 518 ASCs) with declining operating income raises questions about whether growth is being achieved at the cost of profitability.

Comparing 2026-02-17 vs 2025-02-18View on EDGAR →
FINANCIAL ANALYSIS

Operating income declined meaningfully year-over-year, falling approximately 41%, which for an established healthcare operator represents a notable earnings-level headwind. In contrast, operating cash flow expanded substantially — roughly 72% higher — reaching approximately $3.5B, suggesting the income statement decline may be driven by non-cash charges rather than a true deterioration in underlying business economics. The divergence between these two metrics is the central financial story for investors: cash generation appears robust, but the earnings quality and composition of the operating income decline deserve close examination in the full filing.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
+72.9%
$2.0B$3.5B

Operating cash flow surged 72.9% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
-41.1%
$6.0B$3.5B

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

LANGUAGE CHANGES
NEW — 2026-02-17
PRIOR — 2025-02-18
ADDED
As of January 30, 2026, there were 86,963 shares (in thousands) of common stock outstanding.
At December 31, 2025, our Hospital Operations segment was comprised of: (1) 50 acute care and specialty hospitals, a network of employed physicians, and 132 outpatient facilities, including urgent care centers (each, a UCC ), imaging centers, off-campus hospital emergency departments ( EDs ) and micro hospitals; and (2) the revenue cycle management and value based care services we provide to hospitals, health systems, physician practices, employers and other clients through Conifer Health Solutions, LLC.
Our Ambulatory Care segment is comprised of the operations of USPI Holding Company, Inc.
(together with its subsidiaries, USPI ), which held ownership interests in 533 ambulatory surgery centers (each, an ASC ) and 26 surgical hospitals at December 31, 2025.
OPERATIONS In 2025, we continued to strengthen our organization and expand the care we provide while remaining committed to quality, safety and operational excellence.
We enhanced access to higher-acuity services in our communities, advanced ambulatory surgery care, invested in state-of-the-art technology and facilities, and welcomed new team members and physician partners.
In September 2025, we opened the newly constructed, 54-bed Florida Coast Medical Center in Port St.
This acute care hospital offers specialized services, including advanced cardiac care, diagnostic services, an emergency care department, general surgery, neurosciences, orthopedics, robotics and urology.
HOSPITAL OPERATIONS AND SERVICES SEGMENT Our subsidiaries operated 50 acute care and specialty hospitals serving primarily urban and suburban communities in eight states at December 31, 2025.
Kennedy Memorial Hospital Indio 145 Owned San Ramon Regional Medical Center (5) San Ramon 123 JV/Owned Florida Delray Medical Center Delray Beach 536 Owned Florida Coast Medical Center Port Saint Lucie 54 Owned Good Samaritan Medical Center West Palm Beach 333 Owned Palm Beach Gardens Medical Center Palm Beach Gardens 199 Owned St.
REMOVED
As of January 31, 2025, there were 95,121 shares (in thousands) of common stock outstanding.
At December 31, 2024, our Hospital Operations segment was comprised of: (1) 49 acute care and specialty hospitals, a network of employed physicians, and 135 outpatient facilities, including urgent care centers (each, a UCC ), imaging centers, off-campus hospital emergency departments ( EDs ) and micro hospitals; and (2) the revenue cycle management and value based care services we provide to hospitals, health systems, physician practices, employers and other clients through our Conifer Health Solutions, LLC joint venture ( Conifer JV ).
Our Ambulatory Care segment, through our USPI Holding Company, Inc.
subsidiary ( USPI ), held ownership interests in 518 ambulatory surgery centers (each, an ASC ) and 25 surgical hospitals at December 31, 2024.
OPERATIONS HOSPITAL OPERATIONS AND SERVICES SEGMENT In 2024, we continued to pursue advantageous opportunities to grow our portfolio of hospitals and other healthcare facilities.
In July, we opened the newly constructed, 92 bed Westover Hills Baptist Hospital in San Antonio, and, in September, we acquired a majority ownership interest in a 36 bed rehabilitation hospital in El Paso.
In addition, we continued construction in 2024 on a new medical campus located in Port St.
Lucie, which will include the 54 bed Florida Coast Surgical Hospital, as well as medical office space.
To that end, we sold six hospitals in California and three hospitals in South Carolina, along with certain related operations, in 2024; in addition, we completed the sale of our majority ownership interests in several entities that owned or leased five hospitals and certain related operations in Alabama.
At December 31, 2024, our subsidiaries operated 49 acute care and specialty hospitals serving primarily urban and suburban communities in eight states.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →